Thalassemia: an Overview by Abdullatif Husseini - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Thalassemia: an Overview by Abdullatif Husseini

Description:

However if two carriers marry, in each pregnancy there is a 25% chance of a non ... Early prenatal diagnosis can be done using first fetal blood sampling, and later ... – PowerPoint PPT presentation

Number of Views:313
Avg rating:3.0/5.0
Slides: 33
Provided by: Gate287
Category:

less

Transcript and Presenter's Notes

Title: Thalassemia: an Overview by Abdullatif Husseini


1
ß Thalassemiaan Overview by Abdullatif
Husseini
2
What is thalassemia?
  • Thalassemia is a group of inherited disorders of
    hemoglobin synthesis characterized by a reduced
    or absent output of one or more of the globin
    chains of adult hemoglobin .
  • The name is derived from the Greek words
    Thalasso Sea" and "Hemia Blood" in reference
    to anemia of the sea.

3
Alpha (? ) thalassemia
  • It appears when a person does not produce enough
    alpha chains for hemoglobin.
  • It is mainly prevalent in the Africa, the Middle
    East , India, and occasionally in Mediterranean
    region countries.

4
Beta (ß) thalassemia
  • It appears when a person does not produce enough
    beta chains for hemoglobin.
  • It is mainly prevalent in the Mediterranean
    region countries , such as Greece, Cyprus,
    Italy, Palestine and Lebanon.

5
Types of Thalassemia
  • ? thalassemia There are four types categorized
    according to the severity of their effects on
    persons with thalassemia.
  • ß thalassemia There are 3 types categorized
    according to severity
  • Thalassemia minor
  • Thalassemia intermedia
  • Thalassemia major

6
Genetics of ß thalassemia
  • Monogenic disorder a single gene disorder
  • ß thalassemia result from over 150 mutations of
    the ß globin genes that result in the absence or
    a reduction of the ß globin chains

7
Chromosomes
Source Thalassemia.com
8
Transmission of ß thalassemia
  • If a carrier (thalassemia minor) marries a
    non-carrier, on average half of their children
    will be carriers, but none will develop
    thalassemia major.

9
Transmission ß of thalassemia- Cont
  • However if two carriers marry, in each pregnancy
    there is a 25 chance of a non-carrier child, a
    50 chance of a carrier child (thalassemia
    minor), and a 25 chance of a child with
    thalassemia major.

10
An example of inheritancea carrier married to
a normal person
Source Emirates Thalassemia Society
11
An example of inheritance- Contmarriage
between two carriers
Source Emirates Thalassemia Society
12
Types of ß thalassemia
  • Thalassemia Minor (Trait).
  • This can also be called (carrier state),
    meaning that the person carries the genetic trait
    for thalassemia.
  • Such people usually practice normal life, but
    may suffer from a mild form of anemia.

13
Types of ß thalassemia- Cont
  • Thalassemia Intermedia.
  • Caused by the reduced availability of beta
    chains in hemoglobin and can lead to moderate to
    severe anemia and an array of complications
    including bone deformities and splenomegaly.

14
Types of ß thalassemia- Cont
  • Thalassemia Major (Cooley's Anemia).
  • Caused by the unavailability of beta chains in
    hemoglobin leading to a very severe and fatal if
    left untreated anemia.
  • It requires regular blood transfusions leading
    to iron-overload which is treated with chelation
    therapy to prevent death from organ failure.

15
ß thalassemia and malaria
  • Thalassemic RBCs offers protection against severe
    malaria caused by Plasmodium falciparum.
  • The effect is associated with reduced parasite
    multiplication within RBCs.
  • Among the contributing factors may be the
    variable persistence of hemoglobin F, which is
    relatively resistant to digestion by malarial
    hemoglobinases.

16
Signs and symptoms
  • Thalassemia carriers (trait)
  • Usually no signs or symptoms are apparent,
    except for a mild anemia.
  • Carriers are usually initially detected
    through screening, or when performing routine CBC
    (complete blood count). Later it can be confirmed
    using hemoglobin electrophoresis.

17
Signs and symptoms- Cont
  • Thalassemia major
  • Signs such as paleness and growth
    retardation, are readily detectable since the
    first year of life. Those are mainly due to
    severe anemia. Later bone deformities and
    hepato-splenomegaly develops.

18
Laboratory diagnosis
  • Thalassemia minor
  • -Blood smear shows hypochromia and
    microcytosis (similar to Iron Deficiency Anemia).
  • -Blood indices MCVlt 75 fl, Hb usuallygt 10,
    Hematocritgt 30, RDW lt 14.
  • -Hemoglobin A2 often elevated gt 3, sometimes
    reaching 7-8.

19
Laboratory diagnosis- Cont
  • Thalassemia major
  • -Blood smear shows profound microcytic
    anemia, with extreme hypochromia, tear drop,
    target cells and nucleated RBCs.
  • -Hemoglobin may be very low at 3-4 g/dl.

20
Blood picture of a ß thalassemia major patient
Source Cooleys Anemia Foundation
21
Prenatal diagnosis
  • Early prenatal diagnosis can be done using first
    fetal blood sampling, and later chorion villus
    biopsy and direct analysis of the globin genes.
  • The error rate in experienced centers is now well
    under 1.

22
Management and treatment
  • Thalassemia minor (trait)
  • No need for any treatment, since the carriers
    are usually symptomless.
  • Thalassemia major
  • The severe life-threatening anemia, requires
    regular life long blood transfusion, to
    compensate for damaged red blood cells.

23
Management and treatment- Cont
  • Thalassemia Major
  • The continuous blood transfusion will
    eventually lead to iron overload, which must be
    treated with chelation therapy to avoid organ
    failure.

24
Source Cooleys Anemia Foundation
25
Management and treatment- Cont
  • Thalassemia Major -Continued
  • Other novel treatments like bone-marrow
    transplantation are very costly.
  • New treatments includes the use of oral
    chelators, to replace the chelation treatment
    using Desferal delivered by infusion under the
    skin through a battery-operated pump.
  • Gene therapy is also an option still
    researched

26
Prevention efforts
  • Pre marital screening to make sure that the
    couple are not both carriers.
  • Provision of counseling and health education for
    the thalassemics, their families and the public .
  • Provision of prenatal testing for thalassemia.
  • Reduction of marriages between relatives.

27
Thalassemia and migrants
  • Countries with migrants coming from areas with
    high prevalence of thalassemia such as the
    Mediterranean region, should be aware of this
    problem.
  • Families with thalassemia carriers may have
    increased number of cases including thalassemia
    major due to intermarriages between relatives,
    especially in closed communities

28
Thalassemia and migrants -Cont
  • The following recommendations are advised
  • 1- Training physicians and medical staff on
    thalassemia diagnosis and treatment.
  • 2- Provision of screening and counseling
    services for those exposed.
  • 3- Provision of appropriate health care and
    management for thalassemia patients.

29
Thalassemia and migrants -Cont
  • 4- Overcoming the communication problems,
    including language barrier through utilizing
    translators and nurse practitioners.
  • 5- Community educational programs, involving
    community leaders and providing social support.

30
Problems commonly faced by thalassemia major
patients in developing countries
  • Reduced availability of blood for transfusion.
  • Reduced availability of Desferal pumps, less than
    third of the patients have access to pumps.
  • High cost of treatment.

31
Problems commonly faced by thalassemia major
patients in developing countries -Cont
  • Limited services that blood banks are able to
    give.
  • Unavailability of counseling services.
  • Lack of experience and appropriate training among
    the health providers to handle thalassemia cases.

32
Acknowledgement
  • Acknowledgement
  • I would Like to thank Dr. Hisham Darwish Dr.
    Bashar al-Karmi from
  • Thalassemia Patients Friends Society (TPFS)-
    Palestine
  • For the valuable information they provided.
  • I would also like to express my sincere thanks
    for the Palestinian American Research Center
    (PARC) for providing me with a grant which
    allowed me to conduct research at the University
    of Pittsburgh, where I started preparing this
    lecture.
Write a Comment
User Comments (0)
About PowerShow.com